Skip to main content
SpringerLink
Log in

Molecular Diagnosis of Cancer

  • Chapter
  • First Online:
Applications of Biotechnology in Oncology

Abstract

Cancer is a multifactorial disease involving interaction of genetic, environmental, hormonal, and dietary risks. Genes play an important role. Oncogenomics (Chap. 2), sequencing (Chap. 3), oncoproteomics (Chap. 4), and biomarkers (Chap. 5) are relevant to molecular diagnosis of cancer. Basic molecular diagnostic technologies are described in detail in a special report on this topic (Jain 2013). Some of the technologies used for diagnosis of cancer are described in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • André F, Michiels S, Dessen P, et al. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. Lancet Oncol 2009;10:381-90.

    Article  Google Scholar 

  • Ardeshirpour Y, Hassan M, Zielinski R, et al. In Vivo Assessment of HER2 Receptor Density in HER2-positive Tumors by Near-infrared Imaging, Using Repeated Injections of the Fluorescent Probe. TCRT Express 2013;1(2):600265.

    Google Scholar 

  • Bailey VJ, Easwaran H, Zhang Y, et al. MS-qFRET: A quantum dot-based method for analysis of DNA methylation. Genome Res 2009;19: 1455-61.

    Article  CAS  Google Scholar 

  • Bajaj A, Miranda OR, Kim IB, et al. Detection and differentiation of normal, cancerous, and metastatic cells using nanoparticle-polymer sensor arrays. PNAS 2009;106:10912-6.

    Article  CAS  Google Scholar 

  • Balducci A, Wen Y, Zhang Y, et al. A novel probe for the non-invasive detection of tumor-associated inflammation. Oncoimmunology 2013;2(2):e23034.

    Article  Google Scholar 

  • Beck J, Urnovitz H, Mitchell WM, et al. Next Generation Sequencing of Serum Circulating Nucleic Acids from Patients with Invasive Ductal Breast Cancer Reveals Differences to Healthy and Nonmalignant Controls. Mol Cancer Research; 2010;8:335-42.

    Article  CAS  Google Scholar 

  • Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010;463:899-905.

    Article  CAS  Google Scholar 

  • Bignell GR, Greenman CD, Davies H, et al. Signatures of mutation and selection in the cancer genome. Nature 2010;463:893-8.

    Article  CAS  Google Scholar 

  • Bordeaux JM, Cheng H, Welsh AW, et al. Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen. PLoS ONE 2012;7(5):e36559.

    Article  CAS  Google Scholar 

  • Bradley SV, Oravecz-Wilson KI, Bougeard G, et al. Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer. Cancer Res 2005;65:4126-33.

    Article  CAS  Google Scholar 

  • Cahill S, Smyth P, Finn S, et al. Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Mol Cancer 2006b;5:70.

    Article  Google Scholar 

  • Carter SL, Eklund AC, Kohane IS, et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006;38:1043-8.

    Article  CAS  Google Scholar 

  • Chakrabarty A, Sanchez V, Kuba MG, et al. Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors. Proc Natl Acad Sci USA 2012;109:2718-23.

    Article  CAS  Google Scholar 

  • Chen HY, Yu SL, Chen CH, et al. A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer. NEJM 2007;356:11-20.

    Article  CAS  Google Scholar 

  • Cilloni D, Renneville A, Hermitte F, et al. Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study. Journal of Clinical Oncology 2009;27:5195-201.

    Article  CAS  Google Scholar 

  • Dalton-Griffin L, Kellam P. Infectious causes of cancer and their detection. J Biol 2009;8:67.

    Article  Google Scholar 

  • Darragh MR, Schneider EL, Lou J, et al. Tumor Detection by Imaging Proteolytic Activity. Cancer Res 2010;70;1505-12.

    Article  CAS  Google Scholar 

  • Deras IL, Aubin SM, Blase A, et al. PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol 2008;179:1587-92.

    Article  Google Scholar 

  • Di Cristina M, Minenkova O, Pavoni E, et al. A novel approach for identification of tumor-associated antigens expressed on the surface of tumor cells. Int J Cancer 2007;120:1293-303.

    Article  Google Scholar 

  • Diehn M, Nardini C, Wang DS, et al. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. PNAS 2008;105:5213-18.

    Article  CAS  Google Scholar 

  • Duncan CG, Leary RJ, Lin JC, et al. Identification of microbial DNA in human cancer. BMC Med Genomics 2009;2:22.

    Article  Google Scholar 

  • Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-93.

    Article  CAS  Google Scholar 

  • Eisenhauer EA. From the molecule to the clinic—inhibiting HER2 to treat breast cancer. N Engl J Med 2001;344:841-2.

    Article  CAS  Google Scholar 

  • El Hallani S, Ducray F, Idbaih A, et al. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma. Neurology 2009;72:332-6.

    Article  Google Scholar 

  • Fan C, Oh DS, Wessels L, et al. Concordance among Gene-Expression–Based Predictors for Breast Cancer. NEJM 2006;355:560-9.

    Article  CAS  Google Scholar 

  • Feng H, Shuda M, Chang Y, Moore PS: Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-1100.

    Article  CAS  Google Scholar 

  • Feng H, Taylor JL, Benos PV, et al. Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol 2007;81:11332-40.

    Article  CAS  Google Scholar 

  • Gerdes MJ, Sevinsky CJ, Sood A, et al. Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue. Proc Natl Acad Sci U S A 2013;110:11982-11987.

    Article  CAS  Google Scholar 

  • Gong Y, Yan K, Lin F, et al. Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. Lancet Oncology 2007;8:203-11.

    Article  CAS  Google Scholar 

  • Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071-6.

    Article  CAS  Google Scholar 

  • Guyon I, Fritsche HA, Choppa P, et al. A four-gene expression signature for prostate cancer cells consisting of UAP1, PDLIM5, IMPDH2, and HSPD1. UroToday Int J 2009;2(4). doi:10.3834/uij.1944-5784.2009.08.06.

  • Harris TJ, von Maltzahn G, Derfus AM, et al. Proteolytic actuation of nanoparticle self-assembly. Angew Chem Int Ed 2006;45:3161-5.

    Article  CAS  Google Scholar 

  • Helfand BT, Fought AJ, Loeb S, et al. Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk. J Urol 2010;184:501-5.

    Article  Google Scholar 

  • Honda K, Hayashida Y, Umaki T, et al. Possible Detection of Pancreatic Cancer by Plasma Protein Profiling. Cancer Res 2005;65:10613-22.

    Article  CAS  Google Scholar 

  • Hou S, Zhao H, Zhao L, et al. Capture and stimulated release of circulating tumor cells on polymer grafted silicon nanostructures. Adv Mater 2013;25:1547-51.

    Article  CAS  Google Scholar 

  • Hummel M, Bentink S, Berger H, et al. A Biologic Definition of Burkitt’s Lymphoma from Transcriptional and Genomic Profiling. NEJM 2006;354:2419-30.

    Article  CAS  Google Scholar 

  • Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-4.

    Article  CAS  Google Scholar 

  • Jain KK. Application of laser capture microdissection to proteomics. Methods Enzymol 2002;356:157-67.

    Article  CAS  Google Scholar 

  • Jain KK. Molecular Diagnostics. Jain PharmaBiotech, Basel, 2013.

    Google Scholar 

  • Jain KK. Molecular diagnosis of brain tumors. In: Gilman S, editor. MedLink neurology. San Diego: MedLink Corporation (http://www.medlink.com); 2013c.

  • Kishimoto H, Zhao M, Hayashi K, et al. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc Natl Acad Sci U S A 2009;106:14514-7.

    Article  CAS  Google Scholar 

  • Knowles DW, Sudar D, Bator-Kelly C, et al. Automated local bright feature image analysis of nuclear protein distribution identifies changes in tissue phenotype. PNAS 2006;103:4445-50.

    Article  CAS  Google Scholar 

  • Kuznetsov SG, Liu P, Sharan SK. Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat Med 2008;14:875-81.

    Article  CAS  Google Scholar 

  • Labuhn M, Vuaroqueaux V, Fina F, et al. Simultaneous quantitative detection of relevant biomarkers in breast cancer by quantitative real-time PCR. Int J Biol Markers 2006;21:30-9.

    CAS  Google Scholar 

  • Laxman B, Morris DS, Yu J, et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res 2008;68:645-9.

    Article  CAS  Google Scholar 

  • Lazzari C, Spreafico A, Bachi A, et al. Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors. J Thorac Oncol 2012;7:40-8.

    Article  CAS  Google Scholar 

  • Leary RJ, Lin JC, Cummins J, et al. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci U S A 2008;105:16224-9.

    Article  CAS  Google Scholar 

  • Lehman CD, Gatsonis C, Kuhl CK, et al. MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer. NEJM 2007;356:1295-303.

    Article  CAS  Google Scholar 

  • Li J, Makrigiorgos GM. COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing. Biochem Soc Trans 2009;37(Pt 2):427-32.

    Article  CAS  Google Scholar 

  • Loi S, Haibe-Kains B, Desmedt C, et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 2007;25:1239-46.

    Article  CAS  Google Scholar 

  • Ma XJ, Hilsenbeck SG, Wang W, et al. The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol 2006;24:4611-9.

    Article  CAS  Google Scholar 

  • Magnani L, Stoeck A, Zhang X, et al. Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proc Natl Acad Sci U S A 2013;110:E1490-9.

    Article  CAS  Google Scholar 

  • Margraf RL, Mao R, Wittwer CT. Rapid Diagnosis of MEN2B Using Unlabeled Probe Melting Analysis and the LightCycler 480 Instrument. J Mol Diagn 2008;10:123-8.

    Article  CAS  Google Scholar 

  • Marrinucci D, Bethel K, Lazar D, et al. Cytomorphology of circulating colorectal tumor cells: a small case series. J Oncol 2010;2010:861341.

    Article  Google Scholar 

  • Moelans CB, de Weger RA, Ezendam C, van Diest PJ. HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection. BMC Cancer 2009;9:4.

    Article  Google Scholar 

  • Navab R, Strumpf D, Bandarchi B, et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. PNAS 2011;108:7160-5.

    Article  CAS  Google Scholar 

  • Orlova A, Feldwisch J, Abrahmsen L, Tolmachev V. Update: Affibody molecules for molecular imaging and therapy for cancer. Cancer Biotherapy & Radiopharmaceuticals 2007;22;573-84.

    Article  CAS  Google Scholar 

  • Parker JS, Mullins M, Cheang MC, et al. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. J Clin Oncol 2009;27:1160-7.

    Article  Google Scholar 

  • Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807-12.

    Article  CAS  Google Scholar 

  • Patel DA, Shih YJ, Newton DW, et al. Development and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirus. J Virol Methods 2009;160:78-84.

    Article  CAS  Google Scholar 

  • Patz EF Jr, Campa MJ, Gottlin EB, et al. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 2007;25:5578-83.

    Article  Google Scholar 

  • Payne RE, Wang F, Su N, et al. Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients. Br J Cancer 2012;106:1790-7.

    Article  CAS  Google Scholar 

  • Potti A, Mukherjee S, Petersen R, et al. A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer. NEJM 2006;355:570-80.

    Article  CAS  Google Scholar 

  • Quyn AJ, Appleton PL, Carey FA, et al. Spindle Orientation Bias in Gut Epithelial Stem Cell Compartments Is Lost in Precancerous Tissue. Cell Stem Cell 2010;6:175-81.

    Article  CAS  Google Scholar 

  • Robinson K, Creed J, Reguly B, et al. Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay. Prostate Cancer Prostatic Dis 2010;13:126-31.

    Article  CAS  Google Scholar 

  • Russnes HG, Navin N, Hicks J, Borresen-Dale AL. Insight into the heterogeneity of breast cancer through next-generation sequencing. J Clin Invest 2011;121:3810-18.

    Article  CAS  Google Scholar 

  • Ruzza P, Calderan A. Radiolabeled peptide-receptor ligands in tumor imaging. Expert Opin Med Diagn 2011;5:411-24.

    Article  CAS  Google Scholar 

  • Sarosdy MF, Kahn PR, Ziffer MD, et al. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol 2006;176:44-7.

    Article  Google Scholar 

  • Shangguan D, Li Y, Tang Z, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. PNAS 2006;103:11838-43.

    Article  CAS  Google Scholar 

  • Shi H, He X, Wang K, et al. Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration. Proc Natl Acad Sci U S A 2011;108:3900-5.

    Article  CAS  Google Scholar 

  • Skog J, Würdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10:1470-6.

    Article  CAS  Google Scholar 

  • Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006;107:2152-9.

    Article  Google Scholar 

  • Sotiriou C, Pusztai L. Gene-Expression Signatures in Breast Cancer. NEJM 2009; 360:790-800.

    Article  CAS  Google Scholar 

  • Stella GM, Senetta R, Cassenti A, et al. Cancers of unknown primary origin: current perspectives and future therapeutic strategies. J Transl Med 2012;10:12.

    Article  Google Scholar 

  • Stott SL, Hsu CH, Tsukrov DI, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. PNAS 2010;107:18392-7.

    Article  CAS  Google Scholar 

  • Talasaz AH, Powell AA, Huber DE, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. PNAS 2009;106:3970-5.

    Article  CAS  Google Scholar 

  • Tan SJ, Lakshmi RL, Chen P, et al. Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens Bioelectron 2010;26:1701-5.

    Article  CAS  Google Scholar 

  • Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and POC diagnostic algorithms. Leukemia 2008;22:14-22.

    Article  CAS  Google Scholar 

  • Thaxton CS, Elghanian R, Thomas AD, et al. Nanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomy. Proc Natl Acad Sci U S A 2009;106:18437-42.

    Article  CAS  Google Scholar 

  • Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med 2011;364:2305-15.

    Article  CAS  Google Scholar 

  • Van Loo P, Nordgard SH, Lingjærde OC, et al. Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A 2010;107:16910-5.

    Article  Google Scholar 

  • Visintin I, Feng Z, Longton G, et al. Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res 2008;14:1065-72.

    Article  CAS  Google Scholar 

  • Walsh T, Casadei S, Coats KH, et al. Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer. JAMA 2006;295:1379-1388.

    Article  CAS  Google Scholar 

  • Wang H, Zhang W, Fuller GN. Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study. Technol Cancer Res Treat 2006;5:195-9.

    CAS  Google Scholar 

  • Wang S, Liu K, Liu J, et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angew Chem Int Ed Engl 2011;50:3084-8.

    Article  CAS  Google Scholar 

  • Wang S, Wang H, Jiao J, et al. Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angew Chem Int Ed Engl 2009;48:8970-3.

    Article  CAS  Google Scholar 

  • Weigum SE, Floriano PN, Redding SW, et al. Nano-Bio-Chip Sensor Platform for Examination of Oral Exfoliative Cytology. Cancer Prev Res 2010;3;518-28.

    Article  CAS  Google Scholar 

  • Weischer M, Bojesen E, Tybjærg-Hansen A, et al. Increased risk of breast cancer associated with CHEK2*1100delC. J Clin Oncol 2007;25:57-63.

    Article  CAS  Google Scholar 

  • Weiss G, Rösch T. Potential of a new blood test for colorectal cancer screening - the Septin 9 gene biomarker. Eur Oncol 2010;6:51-4.

    Google Scholar 

  • Wilkerson MD, Yin X, Walter V, et al. Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation. PLoS One 2012;7(5):e36530.

    Article  CAS  Google Scholar 

  • Wu K, Li A, Rao M, et al. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol Cell Biol 2006a;26:7116-29.

    Article  CAS  Google Scholar 

  • Yan H, Parsons DW, Jin G, IDH1 and IDH2 Mutations in Gliomas. N Engl J Med 2009;360:765-73.

    Article  CAS  Google Scholar 

  • Yeh IT, Martin MA, Robetorye RS, et al. Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event. Mod Pathol 2009;22:1169-75.

    Article  CAS  Google Scholar 

  • Zheng SL, Sun J, Wiklund F, et al. Cumulative Association of Five Genetic Variants with Prostate Cancer. NEJM 2008;358:910-9.

    Article  CAS  Google Scholar 

  • Zhong L, Hidalgo GE, Stromberg AJ, et al. Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med 2005;172:1308-14.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jain PharmaBiotech, Basel, Switzerland

    Kewal K. Jain MD, FRACS, FFPM

Authors
  1. Kewal K. Jain MD, FRACS, FFPM
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jain, K.K. (2014). Molecular Diagnosis of Cancer. In: Applications of Biotechnology in Oncology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9245-0_6

Download citation

Publish with us

Policies and ethics

Search

Navigation